Deuterium- and Fluorine-18-Labeled Glutamine─a PET Imaging Agent with Enhanced In Vivo Stability
Authors:
Open Access
- 3 July 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (27) , 29741-29753
Abstract
Deuterium and fluorine-18 dual-isotope-labeled fluoroglutamine, (2S,4R)-[4-18F-3,3,4-d3]fluoroglutamine (4-[18F]FGln-d3), was designed, synthesized, and biologically evaluated for its potential as a novel glutamine metabolic imaging agent with improved in vivo stability. The tetradeuterated homoserine 11 intermediate was first synthesized via a six-step synthetic pathway, including a chiral HPLC separation process. Next, (2S,4S)-tosylate precursor 14 was prepared following the reference-reported method, and 4-[18F]FGln-d3 was successfully prepared using a semiautomated production process. After that, a head-to-head comparison of 4-[18F]FGln-d3 with its parent compound 4-[18F]FGln including in vitro cell uptake and in vivo murine animal imaging studies illustrated that the new tracer 4-[18F]FGln-d3 has a similar cell uptake manner and comparable tumor uptake and tumor-to-muscle ratio as 4-[18F]FGln, but moderately decreased radioactivity bone uptake at 120 min postinjection. Overall, the preliminary data from this research indicate the better in vivo stability of 4-[18F]FGln-d3 compared with its counterpart 4-[18F]FGln, which warrants further investigation of this radiotracer as the new PET imaging agent with enhanced stability for probing the glutamine metabolism in vivo.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (R01EB031785)
- Stony Brook University
This publication has 57 references indexed in Scilit:
- The Potential Utility of (2S,4R)-4-[18F]fluoroglutamine as a Novel Metabolic Imaging Marker for Inflammation Explored by Rat Models of Arthritis and Paw EdemaMolecular Imaging and Biology, 2024
- Dynamic PET/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- (2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic ModelsMolecular Imaging and Biology, 2020
- Initial experience in synthesis of (2S,4R)‐4‐[18F]fluoroglutamine for clinical applicationJournal of Labelled Compounds and Radiopharmaceuticals, 2019
- Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[18F]FGln PET ImagingMolecular Imaging and Biology, 2019
- (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical ApplicationMolecular Imaging and Biology, 2019
- Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In VivoMolecular Imaging and Biology, 2016
- Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung CancerMolecular Imaging and Biology, 2015
- Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission TomographyAngewandte Chemie International Edition, 2008
- The role of high rates of glycolysis and glutamine utilization in rapidly dividing cellsBioscience Reports, 1985